These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 33638326)

  • 1. Is BMI a Factor in Compliance to Adjuvant Chemotherapy for Locally Advanced Rectal Cancer?
    Mari GM; Crippa J; Pietro A; Maggioni D; Costanzi A; Scotti MA; Braga M; Cocozza E; Borroni G; Benzoni I; Totaro L; Origi M; Ferrari G; Ziccarelli A; Petri R; Bagnardi V
    Chirurgia (Bucur); 2021; 116(1):51-59. PubMed ID: 33638326
    [No Abstract]   [Full Text] [Related]  

  • 2. Compliance to Adjuvant Chemotherapy of Patients Who Underwent Surgery for Rectal Cancer: Report from a Multi-institutional Research Network.
    Mari GM; Maggioni D; Crippa J; Costanzi ATM; Scotti MA; Giardini V; Garancini M; Cocozza E; Borroni G; Benzoni I; Martinotti M; Totaro L; Origi M; Mazzola M; Ferrari G; Achilli P; Ziccarelli A; Martino A; Petri R; Botta F; Bagnardi V; Pugliese G; Forgione A; Pugliese R;
    World J Surg; 2019 Oct; 43(10):2544-2551. PubMed ID: 31240433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy in Rectal Cancer Patients Treated With Preoperative Chemoradiation and Total Mesorectal Excision: A Multicenter and Retrospective Propensity-Score Matching Study.
    Chung MJ; Lee JH; Lee JH; Kim SH; Song JH; Jeong S; Yu M; Nam TK; Jeong JU; Jang HS
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):438-448. PubMed ID: 30244158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of type of surgery (laparoscopic versus open) on the time to initiation of adjuvant chemotherapy in operable rectal cancers.
    Sinukumar S; Mehta S; Ostwal V; Jatal S; Saklani A
    Indian J Gastroenterol; 2015 Jul; 34(4):310-3. PubMed ID: 26245505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does obesity impact postoperative outcomes following robotic-assisted surgery for rectal cancer?
    Duchalais E; Machairas N; Kelley SR; Landmann RG; Merchea A; Colibaseanu DT; Mathis KL; Dozois EJ; Larson DW
    Surg Endosc; 2018 Dec; 32(12):4886-4892. PubMed ID: 29987562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy comparison of robotic and laparoscopic radical resection of rectal cancer for overweight and obese patients].
    Gao GM; Chen L; Tang HC; Zhu WQ; Huang ZX; Wang DD; Li TY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jan; 24(1):68-74. PubMed ID: 33461255
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection.
    Polanco PM; Mokdad AA; Zhu H; Choti MA; Huerta S
    JAMA Oncol; 2018 Jul; 4(7):938-943. PubMed ID: 29710272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to initiation of postoperative chemotherapy: an outcome measure for patients undergoing laparoscopic resection for rectal cancer.
    Strouch MJ; Zhou G; Fleshman JW; Birnbaum EH; Hunt SR; Mutch MG
    Dis Colon Rectum; 2013 Aug; 56(8):945-51. PubMed ID: 23838862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of obesity in rectal cancer surgery.
    Chern H; Chou J; Donkor C; Shia J; Guillem JG; Nash GM; Paty PB; Temple LK; Wong WD; Weiser MR
    J Am Coll Surg; 2010 Jul; 211(1):55-60. PubMed ID: 20610249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
    Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; McCollum AD; Brady D; O'Connell MJ; Mayer RJ; Cummings B; Willett C; Macdonald JS; Benson AB; Fuchs CS
    J Clin Oncol; 2004 Feb; 22(4):648-57. PubMed ID: 14966087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic versus open surgery for obese patients with rectal cancer: a retrospective cohort study.
    Matsuzaki H; Ishihara S; Kawai K; Murono K; Otani K; Yasuda K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Yamaguchi H; Watanabe T
    Surg Today; 2017 May; 47(5):627-635. PubMed ID: 27677295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Robot Overcome Obesity-related Limitations of Minimally Invasive Rectal Surgery for Cancer?
    Bayraktar O; Aytaç E; Özben V; Atasoy D; Bilgin İA; Erenler Bayraktar İ; Baca B; Hamzaoğlu İ; Karahasanoğlu T
    Surg Laparosc Endosc Percutan Tech; 2018 Feb; 28(1):e8-e11. PubMed ID: 29252933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
    Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
    Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Obesity on the Perioperative, Clinicopathologic, and Oncologic Outcomes of Robot Assisted Total Mesorectal Excision for Rectal Cancer.
    Pai A; Alsabhan F; Park JJ; Melich G; Sulo S; Marecik SJ
    Pol Przegl Chir; 2017 Aug; 89(4):23-28. PubMed ID: 28905801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic colorectal cancer surgery in obese patients.
    Singh A; Muthukumarasamy G; Pawa N; Riaz AA; Hendricks JB; Motson RW
    Colorectal Dis; 2011 Aug; 13(8):878-83. PubMed ID: 20553315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index does not affect postoperative morbidity and oncologic outcomes of total mesorectal excision for rectal adenocarcinoma.
    Ballian N; Yamane B; Leverson G; Harms B; Heise CP; Foley EF; Kennedy GD
    Ann Surg Oncol; 2010 Jun; 17(6):1606-13. PubMed ID: 20077020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of early adjuvant chemotherapy in rectal cancer.
    Noh GT; Han J; Cho MS; Hur H; Lee KY; Kim NK; Min BS
    PLoS One; 2020; 15(1):e0228060. PubMed ID: 32004327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.